[1]
“Comparison of the efficacy and safety of Empagliflozin and Dapagliflozin in uncontrolled type 2 diabetic patients”, Tuj-hlth, vol. 46, no. 5, pp. 303–316, Feb. 2025, Accessed: Nov. 02, 2026. Available: https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/18331